Previous Close | 3.9000 |
Open | 3.9000 |
Bid | 3.0000 |
Ask | 4.5000 |
Strike | 57.50 |
Expire Date | 2026-01-16 |
Day's Range | 3.9000 - 3.9000 |
Contract Range | N/A |
Volume | |
Open Interest | 74 |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats